These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 35755159)

  • 1. An update on
    Dhal AK; Panda C; Yun SI; Mahapatra RK
    J Parasit Dis; 2022 Sep; 46(3):923-939. PubMed ID: 35755159
    [No Abstract]   [Full Text] [Related]  

  • 2. Phenotypic screening techniques for
    Love MS; McNamara CW
    Expert Opin Drug Discov; 2021 Jan; 16(1):59-74. PubMed ID: 32892652
    [No Abstract]   [Full Text] [Related]  

  • 3. A high-throughput phenotypic screen identifies clofazimine as a potential treatment for cryptosporidiosis.
    Love MS; Beasley FC; Jumani RS; Wright TM; Chatterjee AK; Huston CD; Schultz PG; McNamara CW
    PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005373. PubMed ID: 28158186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a Cytopathic Effect-Based Phenotypic Screening Assay against Cryptosporidium.
    Chao AT; Lee BH; Wan KF; Selva J; Zou B; Gedeck P; Beer DJ; Diagana TT; Bonamy GMC; Manjunatha UH
    ACS Infect Dis; 2018 Apr; 4(4):635-645. PubMed ID: 29341586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cryptosporidiosis Drug Discovery: Opportunities and Challenges.
    Manjunatha UH; Chao AT; Leong FJ; Diagana TT
    ACS Infect Dis; 2016 Aug; 2(8):530-7. PubMed ID: 27626293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Life without a Host Cell: What is Cryptosporidium?
    Clode PL; Koh WH; Thompson RCA
    Trends Parasitol; 2015 Dec; 31(12):614-624. PubMed ID: 26440789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel treatment strategies and drugs in development for cryptosporidiosis.
    Chavez MA; White AC
    Expert Rev Anti Infect Ther; 2018 Aug; 16(8):655-661. PubMed ID: 30003818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Breakthroughs and Ongoing Limitations in
    Bhalchandra S; Cardenas D; Ward HD
    F1000Res; 2018; 7():. PubMed ID: 30228873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel drug targets for treatment of cryptosporidiosis.
    Wang B; Castellanos-Gonzalez A; White AC
    Expert Opin Ther Targets; 2020 Sep; 24(9):915-922. PubMed ID: 32552166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Conditional Protein Degradation System To Study Essential Gene Function in Cryptosporidium parvum.
    Choudhary HH; Nava MG; Gartlan BE; Rose S; Vinayak S
    mBio; 2020 Aug; 11(4):. PubMed ID: 32843543
    [No Abstract]   [Full Text] [Related]  

  • 11. In silico identification and validation of a novel hypothetical protein in Cryptosporidium hominis and virtual screening of inhibitors as therapeutics.
    Shrivastava AK; Kumar S; Sahu PS; Mahapatra RK
    Parasitol Res; 2017 May; 116(5):1533-1544. PubMed ID: 28389892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in therapeutic and vaccine targets for Cryptosporidium: Challenges and possible mitigation strategies.
    Rahman SU; Mi R; Zhou S; Gong H; Ullah M; Huang Y; Han X; Chen Z
    Acta Trop; 2022 Feb; 226():106273. PubMed ID: 34906550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cryptic parasite revealed improved prospects for treatment and control of human cryptosporidiosis through advanced technologies.
    Jex AR; Smith HV; Nolan MJ; Campbell BE; Young ND; Cantacessi C; Gasser RB
    Adv Parasitol; 2011; 77():141-73. PubMed ID: 22137584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New methods for the diagnosis of Cryptosporidium and Giardia].
    Cacciò SM
    Parassitologia; 2004 Jun; 46(1-2):151-5. PubMed ID: 15305706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amelioration of Cryptosporidium parvum infection in vitro and in vivo by targeting parasite fatty acyl-coenzyme A synthetases.
    Guo F; Zhang H; Fritzler JM; Rider SD; Xiang L; McNair NN; Mead JR; Zhu G
    J Infect Dis; 2014 Apr; 209(8):1279-87. PubMed ID: 24273180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metal-captured inhibition of pre-mRNA processing activity by CPSF3 controls
    Swale C; Bougdour A; Gnahoui-David A; Tottey J; Georgeault S; Laurent F; Palencia A; Hakimi MA
    Sci Transl Med; 2019 Nov; 11(517):. PubMed ID: 31694928
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug repurposing screen reveals FDA-approved inhibitors of human HMG-CoA reductase and isoprenoid synthesis that block Cryptosporidium parvum growth.
    Bessoff K; Sateriale A; Lee KK; Huston CD
    Antimicrob Agents Chemother; 2013 Apr; 57(4):1804-14. PubMed ID: 23380723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunocompetent rabbits infected with Cryptosporidium cuniculus as an animal model for anti-cryptosporidial drug testing.
    Lu C; Liu X; Liu J; Tang X; Zhu G; Striepen B; Suo X
    Int J Parasitol; 2022 Mar; 52(4):205-210. PubMed ID: 34774541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug Development Against the Major Diarrhea-Causing Parasites of the Small Intestine, Cryptosporidium and Giardia.
    Miyamoto Y; Eckmann L
    Front Microbiol; 2015; 6():1208. PubMed ID: 26635732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Piperazine-Based Drug Lead for Cryptosporidiosis from the Medicines for Malaria Venture Open-Access Malaria Box.
    Jumani RS; Bessoff K; Love MS; Miller P; Stebbins EE; Teixeira JE; Campbell MA; Meyers MJ; Zambriski JA; Nunez V; Woods AK; McNamara CW; Huston CD
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29339392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.